JP2010502689A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502689A5
JP2010502689A5 JP2009527220A JP2009527220A JP2010502689A5 JP 2010502689 A5 JP2010502689 A5 JP 2010502689A5 JP 2009527220 A JP2009527220 A JP 2009527220A JP 2009527220 A JP2009527220 A JP 2009527220A JP 2010502689 A5 JP2010502689 A5 JP 2010502689A5
Authority
JP
Japan
Prior art keywords
compound
furan
methoxydibenzo
cyano
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009527220A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502689A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/002596 external-priority patent/WO2008032171A1/en
Publication of JP2010502689A publication Critical patent/JP2010502689A/ja
Publication of JP2010502689A5 publication Critical patent/JP2010502689A5/ja
Pending legal-status Critical Current

Links

JP2009527220A 2006-09-11 2007-09-10 Pde−4およびpde−10の阻害剤としてのジベンゾフラン誘導体 Pending JP2010502689A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1647CH2006 2006-09-11
PCT/IB2007/002596 WO2008032171A1 (en) 2006-09-11 2007-09-10 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10

Publications (2)

Publication Number Publication Date
JP2010502689A JP2010502689A (ja) 2010-01-28
JP2010502689A5 true JP2010502689A5 (enExample) 2010-10-21

Family

ID=38969801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009527220A Pending JP2010502689A (ja) 2006-09-11 2007-09-10 Pde−4およびpde−10の阻害剤としてのジベンゾフラン誘導体

Country Status (14)

Country Link
US (1) US8263648B2 (enExample)
EP (1) EP2074106B1 (enExample)
JP (1) JP2010502689A (enExample)
CN (1) CN101573348A (enExample)
AU (1) AU2007297221B2 (enExample)
BR (1) BRPI0716804A2 (enExample)
CA (1) CA2663178C (enExample)
IL (1) IL197507A (enExample)
MX (1) MX2009002657A (enExample)
NZ (1) NZ575389A (enExample)
RU (1) RU2009113585A (enExample)
SG (1) SG174810A1 (enExample)
WO (1) WO2008032171A1 (enExample)
ZA (1) ZA200901714B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009115874A2 (en) * 2008-03-17 2009-09-24 Matrix Laboratories Ltd. Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation
ES2443948T3 (es) 2008-12-19 2014-02-21 Bristol-Myers Squibb Company Compuestos de carbazol carboxamida útiles como inhibidores de quinasas
US8580795B2 (en) * 2009-01-22 2013-11-12 Orchid Chemicals & Pharmaceuticals Limited Heterocyclic compounds as phosphodiesterase inhibitors
WO2011132051A2 (en) * 2010-04-19 2011-10-27 Glenmark Pharmaceuticals S.A. Tricycle compounds as phosphodiesterase-10 inhibitors
WO2012112946A1 (en) 2011-02-18 2012-08-23 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
KR102345381B1 (ko) 2013-06-25 2021-12-29 브리스톨-마이어스 스큅 컴퍼니 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물
AR096721A1 (es) 2013-06-25 2016-01-27 Bristol Myers Squibb Co Compuestos de tetrahidrocarbazol y carbazol carboxamida sustituidos
US10039764B2 (en) 2013-07-12 2018-08-07 University Of South Alabama Treatment and diagnosis of cancer and precancerous conditions using PDE10A inhibitors and methods to measure PDE10A expression
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
KR102280686B1 (ko) 2014-02-11 2021-07-22 삼성전자주식회사 카바졸계 화합물 및 이를 포함한 유기 발광 소자
CN106661007B (zh) 2014-08-13 2019-08-13 默克专利有限公司 用于有机电致发光器件的材料
MX393057B (es) 2014-10-24 2025-03-24 Bristol Myers Squibb Co Compuestos de indol carboxamida útiles como inhibidores de cinasas.
TWI676618B (zh) 2014-10-24 2019-11-11 美商必治妥美雅史谷比公司 三環化合物
CN107108555B (zh) 2014-10-24 2020-12-01 百时美施贵宝公司 三环阻转异构体化合物
US20170107216A1 (en) 2015-10-19 2017-04-20 Incyte Corporation Heterocyclic compounds as immunomodulators
MD3377488T2 (ro) 2015-11-19 2023-02-28 Incyte Corp Compuși heterociclici ca imunomodulatori
ES2916874T3 (es) 2015-12-17 2022-07-06 Incyte Corp Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
CA3009474A1 (en) 2015-12-22 2017-06-29 Incyte Corporation Heterocyclic compounds as immunomodulators
ES2906460T3 (es) 2016-05-06 2022-04-18 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
EP3464279B1 (en) 2016-05-26 2021-11-24 Incyte Corporation Heterocyclic compounds as immunomodulators
SG11201811414TA (en) 2016-06-20 2019-01-30 Incyte Corp Heterocyclic compounds as immunomodulators
MA45669A (fr) 2016-07-14 2019-05-22 Incyte Corp Composés hétérocycliques utilisés comme immunomodulateurs
US20180057486A1 (en) 2016-08-29 2018-03-01 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2018119236A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Triazolo[1,5-a]pyridine derivatives as immunomodulators
US10308644B2 (en) 2016-12-22 2019-06-04 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2018119286A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Bicyclic heteroaromatic compounds as immunomodulators
WO2018119221A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Pyridine derivatives as immunomodulators
CN108084128B (zh) * 2017-12-28 2020-01-03 福建中医药大学 一种二苯并呋喃衍生物及其制备方法和用途
SMT202300065T1 (it) 2018-03-30 2023-05-12 Incyte Corp Composti eterociclici come immunomodulatori
CN110407741B (zh) 2018-04-26 2023-03-21 启元生物(杭州)有限公司 一种抗炎化合物及其制备和应用
CN112752756B (zh) 2018-05-11 2024-06-25 因赛特公司 作为PD-L1免疫调节剂的四氢-咪唑并[4,5-c]吡啶衍生物
TW202115059A (zh) 2019-08-09 2021-04-16 美商英塞特公司 Pd—1/pd—l1抑制劑之鹽
JP7559059B2 (ja) 2019-09-30 2024-10-01 インサイト・コーポレイション 免疫調節剤としてのピリド[3,2-d]ピリミジン化合物
EP4058461A1 (en) 2019-11-11 2022-09-21 Incyte Corporation Salts and crystalline forms of a pd-1/pd-l1 inhibitor
GB202002926D0 (en) * 2020-02-28 2020-04-15 Benevolentai Tech Limited Compositions and uses thereof
IL302590A (en) 2020-11-06 2023-07-01 Incyte Corp Process for preparing PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
US11780836B2 (en) 2020-11-06 2023-10-10 Incyte Corporation Process of preparing a PD-1/PD-L1 inhibitor
US11760756B2 (en) 2020-11-06 2023-09-19 Incyte Corporation Crystalline form of a PD-1/PD-L1 inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050065624A (ko) * 2002-10-23 2005-06-29 그렌마크 파머수티칼스 엘티디. 염증성 및 알레르기 질환의 치료에 유용한 신규한트리사이클릭 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물
SI1620429T1 (sl) * 2003-04-11 2009-08-31 Glenmark Pharmaceuticals Sa Nove heterociklične spojine, uporabne za zdravljenje vnetnih in alergijskih motenj: postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
WO2004111044A1 (en) * 2003-06-17 2004-12-23 Glenmark Pharmaceuticals Ltd. Tricyclic compounds useful for the treatment of inflammatory and allergic disorders:process for their preparation
WO2006011024A2 (en) * 2004-07-19 2006-02-02 Glenmark Pharmaceuticals Ltd. New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
WO2006051390A1 (en) * 2004-11-10 2006-05-18 Glenmark Pharmaceuticals S.A. Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, pharmaceutical compositions containing them, and methods of preparing them
PL1831227T3 (pl) * 2004-12-17 2013-10-31 Glenmark Pharmaceuticals Sa Nowe związki heterocykliczne użyteczne w leczeniu stanów zapalnych i dolegliwości alergicznych

Similar Documents

Publication Publication Date Title
RU2009113585A (ru) Производные дибензофурана в качестве ингибиторов pde-4 и pde-10
JP6598974B2 (ja) B型肝炎ウイルス感染症の治療および予防のための新規な三環式4−ピリドン−3−カルボン酸誘導体
AU2012342547C1 (en) Method for producing substituted 5-fluoro-1H-pyrazolopyridines
EP2693876B1 (en) Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
JP6174997B2 (ja) ホスホジエステラーゼ阻害剤としてのベンゾジオキソールまたはベンゾジオキセピンヘテロ環化合物
CA3167023A1 (en) Sulfonimidamide compounds as nlrp3 modulators
EP3747864B1 (en) A method for preparing methyl (z)-3-[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene)-oxindole-6-carboxylate (intedanib, nintedanib)
ZA200603474B (en) Alkoxy substituted imidazoquinolines
JP6621329B2 (ja) 新規化合物、それらの合成及びそれらの使用
JP2017524742A (ja) テトラヒドロキノリン誘導体の調製のための合成中間体の調製方法
RU2010147404A (ru) Замещенные дигидропиразолоны в качестве ингибиторов hif-пролил-4-гидроксилазы
JP2015535839A (ja) ウイルス感染を治療するための1,2,4−トリアジン誘導体
JP2002088073A (ja) 抗アンドロゲン剤
JP2017522339A (ja) 2−アミノ−ベンゾイミダゾール誘導体ならびにこれらの5−リポキシゲナーゼおよび/またはプロスタグランジンeシンターゼ阻害剤としての使用
US9567333B2 (en) Triazolopyridyl compounds as aldosterone synthase inhibitors
KR20090106633A (ko) PDE5 억제제로서 유용한 6-벤질-2,3,4,7-테트라히드로-인돌로[2,3-c]퀴놀린 화합물
WO2022033380A1 (zh) 一种mor受体激动剂化合物、制备方法及其用途
WO2011002103A2 (en) A cycloalkane derivative
JPWO2001021206A1 (ja) NF−κB阻害剤を有効成分とする心筋炎、拡張型心筋症および心不全の予防または治療薬
AU2008274100A1 (en) Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
CA2879816C (en) Methanethione compounds having antiviral activity
JP2022505827A (ja) 置換インドール二量体の化合物
US20080161419A1 (en) Prophylactic Antimigraine Agents
JP2008526818A (ja) Pde10インヒビターとしての新規のピロロジヒドロイソキノリン
JP2018043989A (ja) ブロナンセリンを製造する方法